We are live on ! Find out more
GCP

GSA Capital Partners Portfolio holdings

AUM $1.59B
1-Year Est. Return 39.81%
This Fund
S&P 500
This Quarter Est. Return
-1.68%
1 Year Est. Return
+39.81%
3 Year Est. Return
+94.75%
5 Year Est. Return
+73.44%
10 Year Est. Return
+404.29%
AUM
$1.43B
AUM Growth
+$172M
Cap. Flow
+$215M
Cap. Flow %
15.04%
Top 10 Hldgs %
3.57%
Holding
2,136
New
582
Increased
568
Reduced
423
Closed
559

Top Sells

Rank Stock Value
1
JBSS icon
John B. Sanfilippo & Son
JBSS
+$3.41M
2
APA icon
APA Corp
APA
+$3.31M
3
ZTS icon
Zoetis
ZTS
+$3.2M
4
UGI icon
UGI
UGI
+$3.03M
5
DOCU
DocuSign
DOCU
+$2.87M

Sector Composition

Rank Sector Weight
1 Technology 15.39%
2 Healthcare 13.4%
3 Consumer Discretionary 13.25%
4 Financials 12.49%
5 Industrials 11.39%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
DEM icon
876
WisdomTree Emerging Markets High Dividend Fund
DEM
$3.98B
$568K 0.04%
13,120
-33,496
-72% -$1.44M
NOVA
877
DELISTED
Sunnova Energy
NOVA
$568K 0.04%
101,810
-7,900
-7% -$37.6K
CBRE icon
878
CBRE Group
CBRE
$42.9B
$566K 0.04%
6,349
+2,954
+87% +$262K
FSP
879
Franklin Street Properties
FSP
$46.8M
$564K 0.04%
368,942
+356,184
+2,792% +$670K
TNYA icon
880
Tenaya Therapeutics
TNYA
$163M
$564K 0.04%
182,062
-41,989
-19% -$173K
ECH icon
881
iShares MSCI Chile ETF
ECH
$1.06B
$563K 0.04%
21,780
-23,272
-52% -$637K
MUR icon
882
Murphy Oil
MUR
$4.78B
$563K 0.04%
13,650
+1,794
+15% +$78.2K
NGVC icon
883
Vitamin Cottage Natural Grocers
NGVC
$654M
$563K 0.04%
26,554
-8,067
-23% -$154K
TXO icon
884
TXO Partners LP
TXO
$760M
$563K 0.04%
27,914
+6,014
+27% +$120K
AGL icon
885
Agilon Health
AGL
$1.6B
$562K 0.04%
3,436
-1,033
-23% -$147K
RMNI icon
886
Rimini Street
RMNI
$471M
$562K 0.04%
182,975
+95,959
+110% +$264K
JKHY icon
887
Jack Henry & Associates
JKHY
$11.1B
$561K 0.04%
3,378
-3,321
-50% -$551K
DOCS icon
888
Doximity
DOCS
$4.88B
$559K 0.04%
19,987
+2,597
+15% +$68.5K
KVYO icon
889
Klaviyo
KVYO
$4.73B
$555K 0.04%
+22,310
New +$522K
GTE icon
890
Gran Tierra Energy
GTE
$317M
$554K 0.04%
57,252
+5,926
+12% +$52.9K
CDMO
891
DELISTED
Avid Bioservices, Inc. Common Stock
CDMO
$554K 0.04%
77,597
-15,098
-16% -$115K
TRV icon
892
Travelers Companies
TRV
$80.2B
$551K 0.04%
2,708
+133
+5% +$28.6K
UGI icon
893
UGI
UGI
$7.33B
$551K 0.04%
24,049
-125,137
-84% -$3.03M
YUMC icon
894
Yum China
YUMC
$16.3B
$551K 0.04%
17,862
-26,437
-60% -$968K
MSCI icon
895
MSCI
MSCI
$40.9B
$550K 0.04%
+1,142
New +$567K
GH icon
896
Guardant Health
GH
$22.6B
$549K 0.04%
18,999
-12,292
-39% -$286K
MPTI icon
897
M-tron Industries
MPTI
$380M
$548K 0.04%
+15,577
New +$476K
GFS icon
898
GlobalFoundries
GFS
$29.6B
$547K 0.04%
+10,828
New +$542K
HP icon
899
Helmerich & Payne
HP
$3.71B
$547K 0.04%
+15,144
New +$582K
TDUP icon
900
ThredUp
TDUP
$422M
$547K 0.04%
321,656
-391,604
-55% -$714K

Similar funds

GSA Capital Partners's Q2 2024 Portfolio in Review

As of Q2 2024, GSA Capital Partners held 2,136 positions worth $1.43B, up 14% from $1.26B the previous quarter. Its ten largest holdings account for 3.6% of the portfolio.

GSA Capital Partners deployed $215M of net new capital in Q2 2024, opening 582 new positions and adding to 568 existing holdings. Its largest new stake was Genuine Parts: 28,253 shares worth $3.91M.

By sector, the portfolio is most concentrated in Technology at 15% of assets, down from 16% a quarter earlier, followed by Healthcare and Consumer Discretionary.

On the sell side, the largest reduction was UGI, an estimated $3.03M trimmed.

  • GSA Capital Partners's largest Q2 2024 buy was Genuine Parts: 28,253 shares worth $3.91M.
  • GSA Capital Partners added most to Devon Energy in Q2 2024, an estimated $5.97M increase.
  • GSA Capital Partners's biggest Q2 2024 reduction was UGI, cutting an estimated $3.03M.
  • GSA Capital Partners fully exited John B. Sanfilippo & Son in Q2 2024, selling an estimated $3.41M.
  • GSA Capital Partners's ten largest holdings make up 3.6% of its $1.43B portfolio in Q2 2024.
  • GSA Capital Partners opened 582 new positions and closed 559 in Q2 2024.
  • GSA Capital Partners's portfolio value rose 14% quarter-over-quarter to $1.43B.

Based on GSA Capital Partners's 13F filing for Q2 2024, filed 15 Aug 2024.